2007
DOI: 10.1016/j.bbrc.2007.08.155
|View full text |Cite
|
Sign up to set email alerts
|

Tissue engineering for full-thickness burns: A dermal substitute from bench to bedside

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 15 publications
0
15
0
Order By: Relevance
“…Epidermal stem cells have an important role in wound repair and tissue engineering of replacement skin (Kellouche et al, 2007;Xie et al, 2007). To date, however, the limited capacity for the isolation or purification of significant numbers of epidermal stem cells has hampered their wide clinical application.…”
Section: Introductionmentioning
confidence: 99%
“…Epidermal stem cells have an important role in wound repair and tissue engineering of replacement skin (Kellouche et al, 2007;Xie et al, 2007). To date, however, the limited capacity for the isolation or purification of significant numbers of epidermal stem cells has hampered their wide clinical application.…”
Section: Introductionmentioning
confidence: 99%
“…Some of them are still in the process of in vitro investigation; however, some have entered stage II-III clinical trials and could possibly be on the market shortly available for patients and health practitioners. Novel potential skin substitute biomaterials and scaffolds include human hair keratin-collagen sponge , hyaluronan coupled with fibronectin functional domains (Ghosh et al 2006), poly(lactic-co-glycolic acid)/chitosan hybrid nanofibrous membrane (Duan et al 2007), biodegradable polyurethane microfibres (Rockwood et al 2007), polycaprolactone (PCL) collagen nanofibrous membrane (Venugopal et al 2006), silk fibroin and alginate (Roh et al 2006), polyvinyl alcohol/chitosan/fibroin blended sponge (Yeo et al 2000), Tegaderm-nanofibre construct (Chong et al 2007), bacterial cellulose (Helenius et al 2006), ICX-SKN skin graft replacement (Boyd et al 2007), porcine collagen paste (Shevchenko et al 2008), bovine collagen cross-linked with microbial transglutaminase (Garcia et al 2008), collagen-glycosaminoglycanchitosan dermal matrix seeded with fibroblasts (Kellouche et al 2007), composite nano-titanium oxide-chitosan artificial skin (Peng et al 2008), keratinocytes and fibroblasts grown on Collatamp, deacetylated chitin or plant cellulose transfer membranes (Johnen et al 2008) and many others (table 4). Some of these experimental biomaterials, like PermaDerm, have produced promising clinical results (Boyce et al 1999 and have a potential to be licensed and marketed for clinical use.…”
Section: Potential Biomaterials For Skin Substitutionmentioning
confidence: 99%
“…Autologous or allogeneic PLT concentrate lysates (PCLs), often referred to as PLT‐rich plasma, are used in dentistry; implantology; and orthopedic, plastic, and reconstructive surgery to stimulate the regeneration of hard tissues . They promote the wound healing process of soft tissues and are used for instance to treat recalcitrant leg ulcers and burns . Local injection of PLT lysates has given preliminary encouraging clinical results for reducing pain and improving knee osteoarthritis .…”
mentioning
confidence: 99%